Skip to main content
Veterinary Medicines

Bimacox 2.5 mg/ml Oral Suspension for Lambs and Calves

Authorised
  • Diclazuril

Product identification

Medicine name:
Bimacox 2.5 mg/ml Oral Suspension for Sheep and Cattle
Bimacox 2.5 mg/ml Oral Suspension for Lambs and Calves
Active substance:
  • Diclazuril
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Diclazuril
    2.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BC03
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • 1 litre high density polyethylene container with polypropylene tamper-evident cap with an aluminium seal.
  • 2.5 litre high density polyethylene container with polypropylene tamper-evident cap with an aluminium seal.
  • 5 litre high density polyethylene container with polypropylene tamper-evident cap with an aluminium seal.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bimeda Animal Health Limited
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 50146/3004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0784/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • France
  • Germany
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."